Sun Pharma board to consider Rs 15,000 crore NCD issue
Sun Pharmaceutical Industries said its board will meet on 12 October 2026 to consider issuing listed, rated, unsecured and redeemable non-convertible debentures.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.